The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis

NCT ID: NCT05942248

Last Updated: 2024-08-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-06-06

Study Completion Date

2025-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is conducted to determine if image-based computer grading can of acne, melasma, rosacea and seborrheic dermatitis correlate well to expert based clinical severity grading.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is conducted to determine if image-based computer grading can of acne, melasma, rosacea and seborrheic dermatitis correlate well to dermatologist based clinical severity grading.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acne Melasma Rosacea Seborrheic Dermatitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Acne vulgaris

Inflammatory and non-inflammatory lesion counts

Group Type OTHER

No Intervention

Intervention Type OTHER

No Intervention

Rosacea

Inflammatory lesion count

Group Type OTHER

No Intervention

Intervention Type OTHER

No Intervention

Melasma

Pigment intensity and distribution with use of Melasma Area Severity Index

Group Type OTHER

No Intervention

Intervention Type OTHER

No Intervention

Seborrheic Dermatitis

Grading of seborrheic dermatitis with Seborrheic Dermatitis Area Severity Index score

Group Type OTHER

No Intervention

Intervention Type OTHER

No Intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No Intervention

No Intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults with acne, rosacea, melasma or seborrheic dermatitis

Exclusion Criteria

* Prisoners
* Adults unable to consent
* Artificial facial markings on day of facial photography (such as piercings and tattoos) that may interfere with imaging in the opinion of the investigator
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Codex Labs

UNKNOWN

Sponsor Role collaborator

Integrative Skin Science and Research

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Raja Sivamani, MD, MS, AP

Role: PRINCIPAL_INVESTIGATOR

Integrative Skin and Research

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Integrative Skin and Research

Sacramento, California, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Raja Sivamani, MD, MS, AP

Role: CONTACT

916-750-2463

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Raja Sivamani, MD, MS, AP

Role: primary

916-750-2463

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DERM_AI_IMAGES

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Azelaic Acid on Demodex Counts in Rosacea
NCT03035955 COMPLETED PHASE2/PHASE3